Glucose-lowering properties of vanadium compounds: Comparison of coordination complexes with maltol or kojic acid as ligands

Journal of Inorganic Biochemistry

Volumn 68, Issue 2, 1997, Pages 109-116

  Yuen, Violet G ^a   Caravan, P ^a   Gelmini, Lucio ^a   Glover, Nicholas ^a   McNeill, John H ^a   Setyawati, Ika A ^a   Zhou, Ying ^a   Orvig, Chris ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

KOJIC ACID; MALTOL; VANADIUM DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DIABETES MELLITUS; DRUG ABSORPTION; DRUG CONFORMATION; DRUG EFFECT; DRUG SOLUBILITY; INSULIN LIKE ACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; STREPTOZOCIN DIABETES; STRUCTURE ACTIVITY RELATION;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPOGLYCEMIC AGENTS; MALE; ORGANOMETALLIC COMPOUNDS; PYRONES; RATS; RATS, WISTAR; SOLUTIONS; STRUCTURE-ACTIVITY RELATIONSHIP; TIME FACTORS;

ANIMALIA;

EID: 0030821383     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-0134(97)00082-2     Document Type: Article

References (45)

1. B. I. Posner, A. Shaver, and I. G. Fantus, in New Antidiabetic Drugs, C. J. Bailey, P. R. Flatt, Eds., Smith Gordon, 1990, p. 107.
2. Y. Schlechter, J. Meyerovitch, Z. Farfel, J. Sack, R. Bruck, S. Bar-Meir, S. Amir, H. Degani, and S. J. D. Karlish, in Vanadium in Biological Systems, N. D. Chasteen, Ed., Kluwer, Dordrecht, 1990, p. 129.
3. Y. Schechter, Diabetes 39, 1 (1990).
4. C. Orvig, K. H. Thompson, M. Battell, and J. H. McNeill, Metal Ions Biol. Syst. 31, 575 (1995).
5. Molec. Cell. Biochem. 153 (1995) (special issue on vanadium biochemistry, physiology, and potential use in diabetes therapy).
6. E. L. Tolman, E. Barris, M. Burns, A. Pansisni, and R. Partridge, Life Sci. 25, 1159 (1979).
7. Y. Schechter and S. J. D. Karlish, Nature (London) 284, 556 (1980).
8. G. R. Dubyak and A. Kleinzeller, J. Biol. Chem. 255, 5306 (1980).
9. A. S. Clark, J. M. Fagan, and W. E. Mitch, Biochem. J. 232, 273 (1985).
10. W. C. Duckworth, S. S. Solomon, J. Liepnieks, F. G. Hamel, S. Hand, and D. E. Peavy, Endocrinology 122, 2285 (1988).
11. Y. Shechter and A. Ron, J. Biol. Chem. 261, 14945 (1986).
12. L. C. J. Cantley, L. Josephson, R. Warner, M. Yanagisawa, C. Lechene, and G. Guidotti, J. Biol. Chem. 252, 7421 (1977).
13. L. C. J. Cantley and P. Aisen, J. Biol. Chem. 254, 1781 (1979).
14. N. D. Chasteen, Struct. Bond. (Berlin) 53, 105 (1983).
15. E. Erdmann, K. Werdan, W. Krawietz, W. Schmidt, and H. Scholz, Biochem. Pharmacol. 33, 945 (1984).
16. B. R. Nechay, L. B. Nanninga, P. S. E. Nechay, R. L. Post, J. J. Grantham, I. G. Macara, L. F. Kubena, T. D. Phillips, and F. H. Nielsen, Fed. Proc. 45, 123 (1986).
17. N. D. Chasteen, Vanadium in Biological Systems, Kluwer, Dordrecht, 1990.
18. R. Wever and K. Kustin, Adv. Inorg. Chem. 35, 81 (1990).
19. A. R. Butler and C. J. Carrano, Coord. Chem. Rev. 109, 61 (1991).
20. D. Rehder, Angew. Chem. Int. Ed. Engl. 30, 148 (1991).
21. D. C. Crans, Comments Inorg. Chem. 16, 1 (1994).
22. D. C. Crans, Comments Inorg. Chem. 16, 35 (1994).
23. C. E. Heyliger, A. G. Tahiliani, and J. H. McNeill, Science 227, 1474 (1985).
24. J. L. Domingo, M. Gomez, J. M. Llobet, J. Corbella and C. L. Keen, Toxicology 66, 279 (1991).
25. J. H. McNeill, V. G. Yuen, H. R. Hoveyda, and C. Orvig, J. Med. Chem. 35, 1489 (1992).
26. P. Caravan, L. Gelmini, N. Glover, F. G. Herring, H. Li, J. H. McNeill, S. J. Rettig, I. A. Setyawati, E. Shuter, Y. Sun, A. S. Tracey, V. G. Yuen, and C. Orvig, J. Am. Chem. Soc. 117, 12759 (1995).
27. V. G. Yuen, C. Orvig, and J. H. McNeill, Can J. Physiol. Pharmacol. 71, 263 (1993).
28. V. G. Yuen, C. Orvig, K. H. Thompson, and J. H. McNeill, Can. J. Physiol. Pharmacol. 71, 270 (1993).
29. S. Dai, V. G. Yuen, C. Orvig, and J. H. McNeill, Pharmacol. Commun. 3, 311 (1993).
30. V. G. Yuen, C. Orvig, and J. H. McNeill, Can. J. Physiol. Pharmacol. 73, 55 (1995).
31. V. G. Yuen, C. Orvig, and J. H. McNeill, Am. J. Physiol. 272 (Endocrinol. Metab. 35), E30 (1997).
32. V. G. Yuen, C. Orvig, and J. H. McNeill, Am. J. Physiol. 272 (Endocrinol. Metab. 35), E30 (1997).
33. M. Finnegan, T. G. Lutz, W. O. Nelson, A. Smith, and C. Orvig, Inorg. Chem. 26, 2171 (1987).
34. G. Farrar, A. P. Morton, and J. A. Blair, Fd. Chem. Toxic. 26, 523 (1988).
35. M. A. Barrand, B. A. Callingham, P. Dobbin, and R. C. Hider, Brit. J. Pharmacol. 102, 723 (1991).
36. B. Corain, A. Tapparo, A. A. Sheikh-Osman, G. G. Bombi, P. Zatta, and M. Favarato, Coord. Chem. Rev. 112, 19 (1992).
37. B. Corain, M. Nicolini, and P. Zatta, Coord. Chem. Rev. 112, 33 (1992).
38. S. Bhanot, M. Bryer-Ash, A. Cheung, and J. H. McNeill, Diabetes 43, 857 (1994).
39. G. L. Schieven, A. F. Wahl, S. Myrdal, L. Grosmaire, and J. A. Ledbetter, J. Biol. Chem. 270, 20824 (1995).
40. Y. Sun, B. R. James, S. J. Rettig, and C. Orvig, Inorg. Chem. 35, 1667 (1996).
41. D. Rehder, Magn. Res. Rev. 9, 125 (1984).
42. R. R. Gagne, C. A. Koval, and G. C. Lisensky, Inorg. Chem. 19, 2854 (1980).
43. G. R. Hanson, Y. Sun, and C. Orvig, Inorg. Chem. 35, 6507 (1996).
44. H. Rossotti, The Study of Ionic Equilibria, Longman, London, 1978.
45. U. J. Malabu, S. Dryden, H. D. McCarthy, A. Kilpatrick, and G. Williams, Diabetes 43, 9 (1994).